 Economic Times | Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco ... Economic Times We have several products for the treatment of blood cancer, brain cancer, breast cancer and lung cancer. Therefore, we are essentially a company which is focused on oncology and a major part ... ET Now: Which are some of the key MNCs which are present ... |
